NEC BIRMINGHAM
13-14 OCTOBER 2024

SF68 SLIPIDO

Cerbios-Pharma SA Stand: C64

PROBIOTICS for DYSLIPIDEMIA AND CHOLESTEROL On basis of its proprietary probiotic strain SF68 and its unique characteristics, Cerbios Pharma developed a finished product, for the management of dyslipidemias, cholesterol and metabolic syndrome.

The formulation contains also phytosterols (well known for their efficacy on reduce cholesterol) and folic acid (as 5-MTHF, the active form), that reduces high level of homocystein. Precinical evidences confirm efficacy of the product and we are now running a clinical trial on humans, to confirm existing results. Cerbios is searching for commercial Partners, also in private label.

Loading

OUR 2023 PARTNERS AND SPONSORS

Lead Sponsor

Gold Sponsor

Supported By

Sponsored By

Education Partners

Official Media Partner

Official Digital Partner

Official Publications

Media Partners

Charity Partners

Official Covid & Flu Jab Training

Career Partner

Member Of